Table 1.
Clinical characteristics of 640 non-diabetic individuals from 235 nuclear families
Mean±SD | Median | Range | |
---|---|---|---|
M/F | 246/394 | ||
Age (yrs) | 40.3±14.5 | 40.0 | 16–82 |
BMI (Kg/m2) | 26.3±4.7 | 25.5 | 17.1–48.2 |
Waist circumference (cm) | 84.7±12.6 | 84.0 | 50–126.0 |
SBP (mmHg) | 116.8±14.9 | 115.0 | 80–180 |
DBP (mmHg) | 77.1±9.0 | 80.0 | 50–112 |
FBG (mg/dl) | 90.1±10.3 | 88.2 | 57.7–125.2 |
Insulin (µU/ml) | 8.0±4.6 | 7.1 | 1.8–48.0 |
HOMAIR | 1.8±1.1 | 1.54 | 0.36–10.0 |
Triglycerides (mg/dl) | 100.3±66.1 | 81.0 | 28.0–520.0 |
HDL cholesterol (mg/dl) | 52.9±13.3 | 52.0 | 21–119.0 |
MS (% affected) | 8.4 | ||
CRP (mg/L) | 0.43±0.35 | 0.35 | 0.3–5.0 |
HMW Adiponectin (µg/ml) | 4.3±2.9 | 3.6 | 0.02–24.1 |
MMW Adiponectin (µg/ml) | 1.6±1.5 | 1.2 | 0.01–11.6 |
LMW Adiponectin (µg/ml) | 2.1±1.8 | 1.7 | 0.01–13.5 |
Smokers (%) | 16.5 | ||
Physical exercise >2 hours/week (%) | 15.3 |
BMI: Body Mass Index; SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure; FBG: Fasting Blood Glucose; HOMAIR homeostasis model assessment of insulin-resistance; HDL-Cholesterol: high-density lipoprotein cholesterol; MS: Metabolic Syndrome; CRP: C-reactive protein; HMW: High Molecular Weight; MMW: Medium Molecular Weight; LMW: Low Molecular Weight.